-

Trialbee Releases Initial AI Capabilities Across the Honey Platform™, Launches Intelligent Recruitment Roadmap

Practical AI capabilities throughout Honey support better recruitment decisions for sponsors, CROs and partners while saving time for research sites.

MALMÖ, Sweden & WILMINGTON, Del.--(BUSINESS WIRE)--Trialbee, a global leader in technology-driven patient recruitment, today announced the initial release of AI-powered capabilities across its Honey Platform™. The release is a key milestone in Trialbee’s 2026 Intelligent Recruitment roadmap, reflecting the company’s long-standing mission to reinvent the global patient recruitment ecosystem through innovation.

With this release, Trialbee meaningfully embeds AI features into the Honey Platform™—turning real-world recruitment data into actionable intelligence that helps teams identify risks earlier, reduce administrative burden, and keep recruitment on track. The initial suite of capabilities is highlighted by AI-generated Candidate Summaries which bring key eligibility information to the forefront and significantly reduce the time research sites spend reviewing referred patients’ history and data for faster processing.

“Trialbee’s focus has always been centered on using innovative technology to improve outcomes in global patient recruitment.” said Matt Walz, CEO of Trialbee. “With our Intelligent Recruitment roadmap we are embedding the use of AI-powered capabilities throughout our service and technology offerings, furthering our mission of innovating the way sponsors, CROs, partners and sites work together to find, screen, and enroll patients for their global clinical trials.”

Intelligent Recruitment Capabilities in Newest Release of Honey

Honey’s AI-powered capabilities are designed to support real-world recruitment execution, including:

  • AI-Generated Candidate Summaries that save sites time and increase productivity by consolidating assessments, nurse notes, activity logs, and profile data into a single, actionable snapshot.
  • Duplicate Patient and Spam Detection to protect data integrity and reduce unnecessary workload and cost.
  • Automatic Masking of Potential PII in free-text entries to strengthen privacy and reduce compliance risk without disrupting workflows.
  • Intelligent AI Chatbot that enables Trialbee teams to analyze large volumes of recruitment data, identify emerging risks, and optimize strategies across complex, multi-site trials.
  • Patient Access Optimization that flags potential mismatches such as native language or contact time zones, improving site–patient connections and increasing the likelihood that qualified candidates progress.

Together, these capabilities reinforce Honey as a single source of truth for recruitment, enabling earlier insight, reduced administration, and more predictable global execution.

About Trialbee

Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company’s vendor-agnostic Honey Platform™ is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment — providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Global Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, thoughtfully designed site and patient materials, two-step pre-qualification, and meaningful Omnichannel partners focused on meeting patients where they are in the treatment journey. To take control of patient recruitment for your next study, visit trialbee.com and follow us on LinkedIn.

Contacts

Media Contact
Matt Magliozzo
Gregory
1.732.598.6814
mmagliozzo@gregoryagency.com

Trialbee


Release Versions

Contacts

Media Contact
Matt Magliozzo
Gregory
1.732.598.6814
mmagliozzo@gregoryagency.com

Social Media Profiles
More News From Trialbee

Trialbee Launches AI Pre-Screening Agent in the Honey Platform™ to Help Patients Connect to Clinical Trials Faster

MALMÖ, Sweden & WILMINGTON, Del.--(BUSINESS WIRE)--Trialbee, the global patient recruitment leader advancing technology and AI, is reimagining how patients connect with clinical trials by giving them greater choice over how and when they complete secondary screening through its new AI Pre-Screening Agent in the Honey Platform™. The agent introduces a faster, more flexible path for pre-qualification and participation decisions, and engages patients at the highest moment of interest as they are a...

Trialbee to Present with Takeda, Showcase AI for Clinical Sites, and Unveil AI-Powered Patient Screening at DPHARM 2026

MALMO, Sweden & WILMINGTON, Del.--(BUSINESS WIRE)--Trialbee, the global patient recruitment leader reimagining clinical trials with AI, will present alongside Takeda at DPHARM 2026 taking place September 15–16 in Boston. During the event, Trialbee will unveil AI patient screening in its Honey Platform™, the next release on the Applied AI Recruitment roadmap it published earlier this year. Trialbee will also take an active role participating in a panel on AI technology for clinical sites in the...

Trialbee Appoints Michael Meerovich as Chief Financial Officer to Accelerate Global Growth Strategy

MALMÖ, Sweden & WILMINGTON, Del.--(BUSINESS WIRE)--Trialbee, the global leader in technology-driven patient recruitment, has appointed Michael Meerovich as Chief Financial Officer. Based in New York, Meerovich will play a central role in shaping the company's financial strategy, supporting value creation initiatives, and building the financial foundation required to support Trialbee's expanding global footprint. With AI and new technologies reshaping patient recruitment, Trialbee continues to i...
Back to Newsroom